Press Releases
Ultimovacs Implements Operational Adjustments to Support Continuous Advancement of the UV1 Vaccine Phase II Program
16, April, 2024
Ultimovacs – Invitation to Business Update on April 17, 2024
9, April, 2024
Ultimovacs to Present Poster at the American Association for Cancer Research (AACR) Annual Meeting 2024
4, April, 2024
See all
News
Interview with CEO Carlos de Sousa in Finansavisen TV
14, February, 2024
Biostock Article: About the NIPU study and interview with the Director of Medical Affairs at Ultimovacs, Espen Basmo Ellingsen
6, June, 2023
Ultimovacs Presentation at TD Cowen Healthcare Conference
6, March, 2023
Article published in Current Opinion in Oncology: “Therapeutic cancer vaccination against telomerase”
8, February, 2023
See all